What is Software Solutions?
Software Solutions operates at the intersection of clinical workflow optimization and regulatory compliance, providing a comprehensive suite of digital tools designed to mitigate operational friction in medical environments. The company's core portfolio includes BioDose/NMIS for precise inventory tracking, BioRx/RMIS for integrated dispensing and billing management, and BioTrax QMS, which ensures rigorous adherence to FDA regulatory standards. Furthermore, the Numa platform delivers specialized DICOM and HL7 interoperability solutions, specifically engineered for the complex requirements of nuclear medicine departments. By addressing the dual challenges of administrative efficiency and clinical accuracy, Software Solutions serves as a vital partner for healthcare providers seeking to modernize their internal systems and maintain high-level compliance standards.
How much funding has Software Solutions raised?
Software Solutions has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Software Solutions
PPP
Public-Private Partnership
What's next for Software Solutions?
With the successful closure of this late-stage financing, Software Solutions is poised to transition into a phase of aggressive scaling and product diversification. The strategic allocation of this capital will likely focus on enhancing the interoperability of the Numa platform and expanding the footprint of its QMS offerings in international markets. As the healthcare industry continues to prioritize digital transformation and data-driven clinical management, Software Solutions is strategically aligned to capture increased market share. Future growth initiatives will likely involve deepening the integration of its existing software ecosystem to provide a more unified experience for hospital administrators and clinical staff, thereby reinforcing its competitive advantage in the medical software landscape.
See full Software Solutions company page
